Company: PTPI
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001410578-25-001811
Chunk: 17

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 6E
Chunk 17
---
ITEM 6. EXHIBITS.

Exhibit No.    Description10.1#​Executive Compensation Agreement, by and between Petros Pharmaceuticals, Inc. and Joshua Silverman, dated as of August 13, 2025.31.1*​Rule 13a-14(a)/15d-14(a) Certification – Principal Executive Officer.31.2*​Rule 13a-14(a)/15d-14(a) Certification – Principal Financial Officer.32**​Section 1350 Certification – Principal Executive Officer and Principal Financial Officer. 101​The following materials from Petros Pharmaceuticals, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Operations; (iii) Consolidated Changes in Stockholders’ Equity/Members’ Capital; (iv) Consolidated Statements of Cash Flows; and (v) Notes to the Consolidated Financial Statements.104​Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.

*Filed herewith.

**Furnished herewith.

#Management contract or compensatory plan or arrangement.

​